The genetic epidemiology of prostate cancer and its clinical implications (Q38168060)

30 August 2017

title

The genetic epidemiology of prostate cancer and its clinical implications (English)

1 reference

30 August 2017

1 reference

1 reference

8

Zsofia Kote-Jarai

1 reference

30 August 2017

Elena Castro

3

0 references

Rosalind Eeles

object named as

Rosalind Eeles

1

0 references

Douglas F. Easton

7

object named as

Douglas Easton

1 reference

30 August 2017

Chee Goh

2

1 reference

30 August 2017

Elizabeth Bancroft

4

1 reference

30 August 2017

Michelle Guy

5

1 reference

30 August 2017

Ali Amin Al Olama

6

1 reference

30 August 2017

language of work or name

English

0 references

publication date

3 December 2013

1 reference

30 August 2017

published in

Nature Reviews Urology

1 reference

30 August 2017

volume

11

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

18-31

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Mendelian inheritance of familial prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Transmission disequilibrium, family controls, and great expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome‐wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A candidate prostate cancer susceptibility gene at chromosome 17p

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Evidence for a prostate cancer susceptibility locus on the X chromosome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Evidence for a prostate cancer-susceptibility locus on chromosome 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genomic scan of 254 hereditary prostate cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

No evidence of linkage to chromosome 1q42.2-43 in 131 prostate cancer families from the ACTANE consortium. Anglo, Canada, Texas, Australia, Norway, EU Biomed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genetic counseling for prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Multiple loci on 8q24 associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A common variant associated with prostate cancer in European and African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Evaluating coverage of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

An integrated map of genetic variation from 1,092 human genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Design and coverage of high throughput genotyping arrays optimized for individuals of East Asian, African American, and Latino race/ethnicity using imputation and a novel hybrid SNP selection algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Multiple newly identified loci associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association study identifies new prostate cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Multiple loci identified in a genome-wide association study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Principles for the post-GWAS functional characterization of cancer risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Mutation analysis of the MSMB gene in familial prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Susceptibility loci associated with prostate cancer progression and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Rapid progression of prostate cancer in men with a BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Germline BRCA1 mutations increase prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A recurrent mutation in PALB2 in Finnish cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

NBS1 is a prostate cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Germline mutations in HOXB13 and prostate-cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Hoxb13 is required for normal differentiation and secretory function of the ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Direct-to-consumer personalized genomic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Diet, lifestyle and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate cancer screening in BRCA and Lynch syndrome mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate cancer susceptibility variants confer increased risk of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a “normal” prostate specific antigen and digital rectal examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Association of prostate cancer risk variants with clinicopathologic characteristics of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Utility of incorporating genetic variants for the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Establishment of a Radiogenomics Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genetic Alterations of Androgen Receptor Gene in Japanese Human Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Screening of genetic and expression alterations of SRC1 gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Association of megalin genetic polymorphisms with prostate cancer risk and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

The multiethnic cohort study: exploring genes, lifestyle and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Finding the missing heritability of complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Fine-mapping the putative chromosome 17q21–22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide linkage scan of prostate cancer Gleason score and confirmation of chromosome 19q

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Familial breast cancer in the family-cancer database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Segregation Analysis of Prostate Cancer in Sweden: Support for Dominant Inheritance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer Study (AAHPC)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Where are the prostate cancer genes?—A summary of eight genome wide searches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Cumulative association of five genetic variants with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prostate-cancer screening--what the U.S. Preventive Services Task Force left out

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Tumor Characteristics of Carriers and Noncarriers of the deCODE 8q24 Prostate Cancer Susceptibility Alleles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

SRD5A Polymorphisms and Biochemical Failure After Radical Prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Inherited variation in hormone-regulating genes and prostate cancer survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRUROL.2013.266

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

31 March 2020

1 reference

12 December 2020

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

1 reference

12 December 2020

The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target

1 reference

12 December 2020

A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease

1 reference

12 December 2020

Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies

1 reference

12 December 2020

Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses

1 reference

12 December 2020

A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.

1 reference

12 December 2020

Evaluation of prostate cancer characteristics in four populations worldwide.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2013.266

1 reference

Dimensions Publication ID

30 August 2017

1002687391

0 references

1 reference